Expand AERI Menu
AERI MENU

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 173.7 M 1.73702E+08 226 226 0.04% 0.000421945 158 K 158148
UBIO Proshares UltraPro Nasdaq Biotechnology 25.2 M 2.52193E+07 221 221 0.03% 0.000256453 21 K 20909
URTY ProShares UltraPro Russell2000 87.7 M 8.77399E+07 1,991 1991 0.01% 0.0001001 28 K 27930
UWM ProShares Ultra Russell2000 216.2 M 2.16193E+08 1,991 1991 0.02% 0.000157833 73 K 72801
FAD First Trust Multi Cap Growth AlphaDEX Fund 193.9 M 1.93894E+08 674 674 0.04% 0.0004 75 K 74863
FYC First Trust Small Cap Growth AlphaDEX Fund 220.8 M 2.20751E+08 262 262 0.2% 0.002 438 K 438228
FYX First Trust Small Cap Core AlphaDEX Fund 556.7 M 5.56706E+08 525 525 0.05% 0.0005 288 K 288346
VB Vanguard Small-Cap ETF 28.6 B 2.86E+10 1,345 1345 0.02% 0.000247429 7.3 M 7331730
VBR Vanguard Small-Cap Value ETF 14.5 B 1.45E+10 852 852 0.05% 0.000458544 6.8 M 6786130
VHT Vanguard Health Care ETF 9.8 B 9.799999E+09 387 387 0.02% 0.000216215 2.1 M 2126610
VTWG Vanguard Russell 2000 Growth ETF 338.9 M 3.389E+08 1,171 1171 0.08% 0.000799054 280 K 279565
IBB iShares Nasdaq Biotechnology Index Fund 7.0 B 7.00087E+09 215 215 0.11% 0.0011 8.2 M 8155850
IHE iShares U.S. Pharmaceutical ETF 354.6 M 3.54627E+08 45 45 0.31% 0.0031 1.1 M 1115750
ITOT iShares Core S&P Total U.S. Stock Market ETF 26.3 B 2.63131E+10 3,660 3660 0.0% 0 629 K 628741
IWM iShares Russell 2000 ETF 45.2 B 4.51845E+10 1,981 1981 0.04% 0.0004 17.5 M 1.75085E+07
IWO iShares Russell 2000 Growth ETF 10.1 B 1.00609E+10 1,163 1163 0.07% 0.0007 7.4 M 7418060
IWV iShares Russell 3000 ETF 10.5 B 1.05227E+10 2,878 2878 0.0% 0 272 K 271969
IEIH iShares Evolved U.S. Innovative Healthcare ETF 5.7 M 5724620 232 232 0.06% 0.0006 3,501 3501
SCHA Schwab U.S. Small-Cap ETF 9.3 B 9.30899E+09 1,745 1745 0.03% 0.0003 2.6 M 2622113
SCHB Schwab U.S. Broad Market ETF 17.0 B 1.6984E+10 2,483 2483 0.0% 0 405 K 405046
XPH SPDR S&P Pharmaceuticals ETF 272.9 M 2.7287E+08 41 41 2.58% 0.025803 7.0 M 7036116
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.5 B 1.48129E+09 2,223 2223 0.01% 5.1E-05 74 K 74459
HDGE Ranger Equity Bear Bear ETF 120.5 M 1.20482E+08 68 68 -0.01% -0.000137 -1.7 M -1653250
FHLC Fidelity MSCI Health Care Index ETF 1.8 B 1.8E+09 361 361 0.02% 0.000191336 348 K 347569
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000185257 389 K 389394